Sumatriptan is an FDA approved serotonin 5-HT1 receptor agonist also known as a “triptan” class drug. It is indicated in the treatment of migraine headaches with or without aura and cluster headaches. Sumatriptan narrows the blood vessels in the brain.
Sumatriptan is not a preventative drug, but alleviates symptoms such as pain, sensitivity to light and sound and nausea for acute headaches. This drug is, usually, well tolerated. The active pharmaceutical ingredient can be delivered in tablets, inhalers, injectable solutions, and topical creams.
Pharmaceutica North America provides Sumatriptan as a Bulk Active Pharmaceutical Ingredient (API). The purity and strength of API’s ensure that you are providing your patients with a stable, safe medication of the highest standards.